Michael Brady & Co’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$303K Sell
3,062
-16
-0.5% -$1.67K 0.27% 44
2026
Q2
$279K Sell
3,078
-275
-8% -$25.1K 0.25% 46
2026
Q1
$344K Sell
3,353
-85
-2% -$9.6K 0.35% 40
2025
Q4
$431K Buy
+3,438
New +$438K 0.43% 33

Other funds holding ABT

Michael Brady & Co's ABT Position: Q3 2026 in Review

Michael Brady & Co reduced its Abbott (ABT) stake by 0.52% in Q3 2026, selling an estimated $1.67K and leaving 3,062 shares worth $303K. The position accounts for 0.27% of the portfolio, ranked #44.

Michael Brady & Co first reported a position in ABT in Q4 2025 and has held it in 4 quarters since. The position peaked at $431K in Q4 2025. 3,043 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • Michael Brady & Co held 3,062 shares of Abbott worth $303K as of Q3 2026.
  • Michael Brady & Co sold 16 Abbott shares in Q3 2026, an estimated $1.67K.
  • Abbott made up 0.27% of Michael Brady & Co's portfolio in Q3 2026, its #44 holding.
  • Michael Brady & Co first reported a position in Abbott in Q4 2025 and has held it in 4 quarters since.
  • Michael Brady & Co's Abbott position peaked at $431K in Q4 2025.
  • 3,043 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Michael Brady & Co's 13F filing for Q3 2026, filed 23 Oct 2026.